| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/01/2005 | CN1621084A Anti HIV product containing green tea active substance |
| 06/01/2005 | CN1621081A Preparation of isotomic injecta containing cordate houttuynia and honeysuckle flower and its preparation method |
| 06/01/2005 | CN1621071A Mini pills for treating cold and its preparation method |
| 06/01/2005 | CN1621064A Chinese medicine for treating wind-warm disease |
| 06/01/2005 | CN1621062A Chinese traditional medicinal injection for treating chronic hepatitis |
| 06/01/2005 | CN1621053A Medicine for treating hepatitis B |
| 06/01/2005 | CN1621045A Externally applied liniment containing propolis |
| 06/01/2005 | CN1621043A Powder injection preparation of diammonium glycyrrhizinate and its preparation |
| 06/01/2005 | CN1621038A Usage of glanthidine, total alkali extract and preparation method and usage thereof |
| 06/01/2005 | CN1621028A Powder for washing feet |
| 06/01/2005 | CN1204258C Component of bromelain |
| 06/01/2005 | CN1204253C Neisseria lactoferrin binding protein |
| 06/01/2005 | CN1204251C Process for preparing VP2 protein from master host protective antigen (VP2) gene of infections burse disease virus (IBDV) and its gene engineering |
| 06/01/2005 | CN1204248C Process for preparing target ribonuclease for curing hepatitis B virus infection |
| 06/01/2005 | CN1204144C Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/01/2005 | CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy |
| 06/01/2005 | CN1203892C Aqueous solution formulation of alpha-interferon |
| 06/01/2005 | CN1203888C Medicine for treating various fungal skin disease or bromidrosis |
| 06/01/2005 | CN1203881C Medicine for curing cold and influenza and complication and its preparing process |
| 06/01/2005 | CN1203872C Medicine for treating chronic colitis |
| 06/01/2005 | CN1203862C Compound glucose injection with clindamycin and metronidazole |
| 06/01/2005 | CN1203856C Dispersion tablet of vasilowy hydrochlaride and its preparation method |
| 06/01/2005 | CN1203851C Use of inhibitor produced or released by reactive oxygen metablite in producing pharmaceutical |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900344 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 05/31/2005 | US6900338 Scavenger compounds |
| 05/31/2005 | US6900334 Antiallergens; autoimmune diseases |
| 05/31/2005 | US6900309 Aminocarbonylation reaction of a adenosine compound containing purine base and pentofuranosyl sugar and a leaving group at 2 position of purine ring, with an amine compound in presence of carbon monoxide and suitable coupling catalyst |
| 05/31/2005 | US6900302 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 05/31/2005 | US6900243 Phenylheteroalkylamine derivatives |
| 05/31/2005 | US6900242 Compound for use in the treatment of cancer and prevention of infections |
| 05/31/2005 | US6900238 HIV protease inhibitors |
| 05/31/2005 | US6900235 Anticancer agents; viricides |
| 05/31/2005 | US6900225 Quinolonecarboxylic acid derivative |
| 05/31/2005 | US6900224 Effective against a broad range of pathogenic microorganisms with advantages in low susceptibility to microbial resistance, reduced toxicity, and improved pharmacology. |
| 05/31/2005 | US6900211 CCR5 antagonists useful for treating aids |
| 05/31/2005 | US6900201 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/31/2005 | US6900195 Administering to a subject an effective amount of a manzamine, manzamine derivative or analog or isomer to treat bacterial, parasitic, viral and other infections |
| 05/31/2005 | US6900183 Macrolide antibiotics |
| 05/31/2005 | US6900175 Administering teichoplanin |
| 05/31/2005 | US6900161 Azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 05/31/2005 | US6900160 Triazolo-epothilones |
| 05/31/2005 | US6900055 Oxygen permeable biocompatible elastomer for propagating viable tissue; tissue engineering |
| 05/31/2005 | US6900043 Phosphatases which activate map kinase pathways |
| 05/31/2005 | US6900035 Comprises human papilloma virus (HPV) fusion between mycobacterial chaperone protein and viral E6 protein for use in treating tumors |
| 05/31/2005 | US6900027 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents |
| 05/31/2005 | US6899900 Composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator |
| 05/31/2005 | US6899890 Bioadhesive drug delivery system |
| 05/31/2005 | US6899884 Vaccine against mumps containing a jeryl-lynn virus strain |
| 05/31/2005 | US6899868 Iodine/resin disinfectant and a procedure for the preparation thereof |
| 05/31/2005 | US6899867 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 05/31/2005 | CA2332929C Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles |
| 05/26/2005 | WO2005047333A1 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications therof |
| 05/26/2005 | WO2005046748A1 Device and method for attracting diseased cells and foreign substances |
| 05/26/2005 | WO2005046567A2 Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same |
| 05/26/2005 | WO2005046358A1 Method of using whole olive and food having activity against helicobacter pylori |
| 05/26/2005 | WO2005000843A3 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 05/26/2005 | US20050113773 irradiating a paste mixture of chitin and/or chitosan derivatives, to form hydrogels having antimicrobial activity, used in disposable diapers or as humectants in cosmetics |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113424 E.g., 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperazinyl]propoxy}benzamidine; an antifungal agent with good pharmacokinetics and excellent antifungal action; side effect reduction such as nephrotoxicity; action to Mycomycetes |
| 05/26/2005 | US20050113414 1-[1-((E)-1-Cyclooct-1-enyl)methylpiperidin-4-yl]-3-(3,4-dichlorophenyl)-urea; potent and selective modulators of CXCR3, a chemokine receptor; antagonists; treatment of conditions involving inappropriate T-cell trafficking; antiinflammatory, -arthritic agents, autoimmune diseases; antiallergens |
| 05/26/2005 | US20050113404 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates |
| 05/26/2005 | US20050113397 Broad spectrum antifungal agent; 1,6-beta-glucan synthetase inhibitors; pyrido(1,2-a)benzimidazole derivatives or benzo(4,5)imidazo(1,2-a)pyridine derivatives |
| 05/26/2005 | US20050113393 Treating human herpes virus, human immunodeficiency virus, and hepatitis B virus; optionally administered with other antiviral agents; (E)-9-{[2,2-bis-(hydroxymethyl)cyclopropylidene]methyl}adenine |
| 05/26/2005 | US20050113371 Antifungal agent for topical use |
| 05/26/2005 | US20050113370 Therapeutic substituted indazole derivatives |
| 05/26/2005 | US20050113361 Amide derivatives as NMDA receptor antagonists |
| 05/26/2005 | US20050113360 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/26/2005 | US20050113359 NMDA (N-methyl-D-aspartate) receptors; eg 1-[4-(4-fluoro-benzyl)-piperidin-1-yl]-1-(6-hydroxy-1H-indole-2-yl)methanone |
| 05/26/2005 | US20050113347 Novel antibacterial compounds: process for their preparation and pharmaceutical compositions containing them |
| 05/26/2005 | US20050113331 Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors |
| 05/26/2005 | US20050113321 DAPD combination therapy with inosine monophosphate dehydrogenase inhibitor |
| 05/26/2005 | US20050113304 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression |
| 05/26/2005 | US20050113284 Drug for regenerating tissue and vessel and method therefor |
| 05/26/2005 | US20050112565 Proteases |
| 05/26/2005 | US20050112563 Sub-sequences of 2'-deoxy-erythro-pentofuranosyl nucleotides that activate RNase H enzyme; diagnostics; antisense therapeutics |
| 05/26/2005 | US20050112206 Mixture of drug, aminoacrylate polymer and acid |
| 05/26/2005 | US20050112182 Medical adhesive and medical covering agent using ultraviolet ray curable chitosan derivative |
| 05/26/2005 | US20050112145 Dna vaccines coding antigen |
| 05/26/2005 | US20050112144 Deactivated, cell-free; culture product using protease; harvesting; separation |
| 05/26/2005 | US20050112136 Human immunodeficiency virus vaccine |
| 05/26/2005 | CA2545679A1 Biotin-facilitated transport in gram negative bacteria |
| 05/26/2005 | CA2545182A1 Improved methods and compositions for rna interference |
| 05/26/2005 | CA2544349A1 Rna amidates and thioamidates for rnai |
| 05/26/2005 | CA2543629A1 2-phenyl-benzofuran derivatives, method for the production thereof and their use |
| 05/25/2005 | EP1533380A2 Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus |
| 05/25/2005 | EP1533320A1 HUMAN IgM ANTIBODY INDUCING APOPTOSIS IN HIV-INFECTED CELLS AND REMEDY FOR HIV-INFECTION |
| 05/25/2005 | EP1532977A1 Antifungal agents for external use |
| 05/25/2005 | EP1532434A1 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 05/25/2005 | EP1532253A1 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine |
| 05/25/2005 | EP1532248A1 Modified small interfering rna molecules and methods of use |
| 05/25/2005 | EP1532238A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 05/25/2005 | EP1532164A1 Template-fixed peptidomimetics with antibacterial activity |
| 05/25/2005 | EP1532157A2 Novel phosphonic acid based prodrugs of pmea and its analogues |
| 05/25/2005 | EP1532153A1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| 05/25/2005 | EP1532137A2 Antimicrobial aza-bicyclic derivates, their compositions and uses |
| 05/25/2005 | EP1532135A1 Nf-kb inhibitors |
| 05/25/2005 | EP1532133A1 Nf-:b inhibitors |
| 05/25/2005 | EP1532129A1 Sorbicillactone-a derivatives for the treatment of tumour and viral diseases |
| 05/25/2005 | EP1532128A1 Inhibitors of hcv ns5b polymerase |